Related Experiment Video

Updated: Jul 2, 2026

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Empiric antibiotic therapy in children with community-acquired pneumonia

Linjie Zhang1, Raquel Lovatel, Dilvania Nicolete

  • 1Department of Maternal and Child Health, Federal University of Rio Grande, Rio GrandeRS, Brazil. zhanglinjie63@yahoo.com.br

Indian Pediatrics
|August 13, 2008
PubMed

Insights

Empiric antibiotic therapy remains effective for childhood community-acquired pneumonia, despite a slight rise in antibiotic resistance over time. This study analyzed treatment responses in hospitalized children from 1991-2001.

Area of Science:

  • Pediatric infectious diseases
  • Clinical pharmacology

Background:

  • Community-acquired pneumonia (CAP) is a common childhood illness.
  • Empiric antibiotic therapy is the standard treatment for presumed bacterial CAP.
  • Assessing treatment response over time is crucial for guiding clinical practice.

Purpose of the Study:

  • To evaluate changes in clinical response to empiric antibiotics in children with CAP.
  • To identify trends in treatment effectiveness and antibiotic resistance.
  • To analyze the duration of hospitalization in relation to antibiotic therapy.

Main Methods:

  • Retrospective observational study of 893 children (29 days to 12 years).
  • Review of medical records for diagnosis of presumed bacterial pneumonia.
  • Extraction of data on patient response to empiric antibiotics and length of hospital stay.

Main Results:

  • Penicillin and derivatives were the most frequent empiric antibiotics used.
  • Antibiotic failure rates increased significantly from 3.8% (1991-1998) to 11.4% (1999-2001).
  • Inadequate antibiotic coverage and presumed resistance were key reasons for failure; length of stay showed no significant change.

Conclusions:

  • Empiric antibiotic therapy demonstrated effectiveness for childhood CAP between 1991-2001.
  • A slight increase in presumed antibiotic resistance was observed in the later study period.
  • Continued monitoring of antibiotic resistance patterns is warranted.
Abstract

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...